Showing results (31-40 of 216) with videos related to
Sort By:
Pageof 22
Antimicrobial Agents and Chemotherapy|May 17, 2001
In vitro activities of ertapenem (MK-0826) against clinical bacterial isolates from 11 North American medical centersP C Fuchs, A L Barry, S D BrownEuropean Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 29, 1999
Antibacterial activity of moxifloxacin (Bay 12-8039) against aerobic clinical isolates, and provisional criteria for disk susceptibility testsA L Barry, P C Fuchs, S D BrownJournal of Clinical Microbiology|July 1, 1993
Levofloxacin disk potency and tentative interpretive criteria for susceptibility testsM A Pfaller, A L Barry, P C FuchsJournal of Clinical Microbiology|July 1, 1993
Ramoplanin susceptibility testing criteriaA L Barry, M A Pfaller, P C FuchsAmerican Journal of Surgery|May 1, 1984
Antimicrobial prophylaxis in elective colon surgery. Experience of 1,035 operations in a community hospitalJ J Peck, P C Fuchs, M E GustafsonJournal of Clinical Microbiology|January 1, 1997
Interpretive criteria and quality control parameters for testing of susceptibilities of Haemophilus influenzae and Streptococcus pneumoniae to trimethoprim and trimethoprim-sulfamethoxazole. The Antimicrobial Susceptibility Testing OC GroupP C Fuchs, A L Barry, S D BrownThe Journal of Antimicrobial Chemotherapy|January 1, 1993
RO 23-9424, a new cephalosporin 3'-quinolone: in-vitro antimicrobial activity and tentative disc diffusion interpretive criteriaM A Pfaller, A L Barry, P C FuchsDiagnostic Microbiology and Infectious Disease|April 1, 1996
Survey of antimicrobial activity of four commonly used third generation cephalosporins tested against recent bacterial isolates from ten American medical centers, and assessment of disk diffusion test performance. AST Surveillance GroupP C Fuchs, A L Barry, S D BrownAntimicrobial Agents and Chemotherapy|January 1, 1993
Susceptibilities of beta-lactamase-producing and -nonproducing ampicillin-resistant strains of Haemophilus influenzae to ceftibuten, cefaclor, cefuroxime, cefixime, cefotaxime, and amoxicillin-clavulanic acidA L Barry, P C Fuchs, M A PfallerThe Journal of Antimicrobial Chemotherapy|December 16, 1998
Susceptibility to RPR 106,972, quinupristin/dalfopristin and erythromycin among recent clinical isolates of enterococci, staphylococci and streptococci from North American medical centresA L Barry, P C Fuchs, S D BrownPageof 22